Nnyefe ọgwụ ezubere iche maka ọrịa kansa: ntuziaka zuru oke 

Ezubere ịnye ọgwụ maka ọrịa kansa bu n'obi imeziwanye ọgwụgwọ ọgwụgwọ yana ibelata mmetụta ya site n'ịhọpụta ndị na-ahụ maka ọgwụgwọ na mkpụrụ ndụ kansa ma na-echekwa anụ ahụ dị mma. Usoro a na-enye ndị na-ebu dị iche iche na atụmatụ ebumnuche iji kwalite mkpokọta ọgwụ n'ime microenvironment tumor, na-eduga na nsonaazụ ndị ọrịa ka mma.

Nghọta Nnyefe ọgwụ ezubere iche maka ọrịa kansa

Gịnị bụ Nnyefe ọgwụ ezubere iche maka ọrịa kansa?

Ezubere ịnye ọgwụ maka ọrịa kansa bụ usoro ọkaibe nke inye ọgwụ ozugbo na mkpụrụ ndụ kansa. N'adịghị ka chemotherapy ọdịnala, nke na-emetụta ahụ dum, usoro nnyefe ezubere iche na-elekwasị anya n'ebuga ọgwụ kpọmkwem na saịtị etuto ahụ. Ụzọ a na-ebelata mmebi nke anụ ahụ dị mma ma na-ebelata mmetụta ọjọọ ndị na-ejikọta ya na ọgwụgwọ ọrịa cancer.

Gịnị kpatara ya Nnyefe ọgwụ ezubere iche maka ọrịa kansa Ọ dị mkpa?

Ihe mgbaru ọsọ mbụ nke nnyefe ọgwụ ezubere iche maka ọrịa kansa bụ ịkwalite ịdị irè nke ọgwụgwọ ọrịa kansa ma na-ebelata mmetụta nsị na sel ahụike. Site n'ibunye ọgwụ ozugbo na etuto ahụ, enwere ike nweta ọkwa dị elu nke onye na-ahụ maka ọgwụgwọ na saịtị ebumnuche, na-eme ka ohere nke ọgwụgwọ na-aga nke ọma. Nke a na-ebelatakwa ikpughe usoro ahụ na ọgwụ ahụ, na-eduga n'inwe mmetụta dị ntakịrị ma dị ntakịrị maka onye ọrịa.

Na-eru nso Nnyefe ọgwụ ezubere iche maka ọrịa kansa

Ntụle na-agafe agafe

Nlebara anya na-agafe agafe na-adabere na njirimara ebumpụta ụwa nke etuto ahụ, dị ka vasculature ha na-agbapụta na mmiri mmiri na-adịghị mma, iji kwe ka ọgwụ na-agbakọta na microenvironment tumor. Nanoparticles nwere nha kwesịrị ekwesị na ihe ndị dị n'elu nwere ike iji atụmatụ ndị a na-eme ihe na etuto ahụ. Otu ihe atụ bụ liposomes nke bụ vesicles okirikiri nke nwere lipid bilayers mejupụtara.

Ezubere iche na-arụ ọrụ

Ebumnuche na-arụsi ọrụ ike gụnyere imegharị ndị na-ebu ọgwụ nwere ligands a kapịrị ọnụ nke na-ejikọta na ndị na-anabata ya nke ukwuu na mkpụrụ ndụ kansa. Mmekọrịta a na-eme ka mkpụrụ ndụ kansa nwee ike ịhọrọ ndị na-ebu ọgwụ. Njikọ ndị a na-ahụkarị gụnyere ọgwụ mgbochi, peptides, na aptamers.

Ntụle mkpali na-anabata

Ebumnuche na-anabata mkpali na-eji mkpali ime ma ọ bụ mpụga, dị ka pH, okpomọkụ, ma ọ bụ ọkụ, kpalite mwepụta ọgwụ na saịtị etuto ahụ. Ụzọ a na-enye ohere maka njikwa ziri ezi na nnyefe ọgwụ, na-eme ka ọgwụgwọ ọgwụgwọ dịkwuo elu ma na-ebelata mmetụta ndị a na-atụghị anya ya. PH-sensitive nanoparticles, dịka ọmụmaatụ, na-ahapụ ibu ọgwụ ha na gburugburu acidic nke microenvironment tumor.

Ndị na-ebubu ejiri Nnyefe ọgwụ ezubere iche maka ọrịa kansa

Ihe nanoparticles

A na-ejikarị nanoparticles eme ihe dị ka ndị na-ebu ya nnyefe ọgwụ ezubere iche maka ọrịa kansa n'ihi obere nha ha, nnukwu ebe elu, na ike dị iche iche. Enwere ike ime ha site na ihe dị iche iche, gụnyere lipids, polymers, na ogige inorganic. Enwere ike imezi ihe nanoparticles iji kpuchie ọgwụ, chebe ha pụọ ​​​​na nbibi, na ịkwado nnyefe ha ezubere iche na mkpụrụ ndụ kansa. Nke Shandong Baofa Cancer Research Institute na-eji ụdị nanoparticles dị iche iche na nyocha ha na-aga n'ihu n'ime usoro ọgwụgwọ ọrịa cancer ọhụrụ.

Liposomes

Liposomes bụ vesicles dị okirikiri nke mejupụtara lipid bilayers. Ha bụ ihe na-emekọrịta ihe, na-emebi emebi, ma nwee ike itinye ma ọgwụ hydrophilic na hydrophobic. Enwere ike gbanwee liposomes site na iji ligands lekwasịrị anya iji kwalite nhọrọ ha maka mkpụrụ ndụ kansa.

Njikọ Antibody-Drug Conjugates (ADCs)

ADC bụ ihe mgbochi monoclonal jikọtara ya na ọgwụ cytotoxic. Ihe mgbochi ahụ na-ejikọ aka na mkpụrụ ndụ kansa, na-ebuga ọgwụ ahụ ozugbo na saịtị etuto ahụ. Ụzọ a na-ejikọta nkọwa nke ọgwụ nje na ike nke ọgwụ cytotoxic.

Ọmụmaatụ nke Nnyefe ọgwụ ezubere iche maka ọrịa kansa na Clinical Jiri

Doxil? (Liposomal Doxorubicin)

Doxil? bụ ụdị liposomal nke doxorubicin, ọgwụ chemotherapy anthracycline. Ihe mkpuchi liposomal nke doxorubicin na-agbatị oge mgbasa ya ma na-eme ka mkpokọta ya dị na etuto ahụ nwere vasculature leaky. Doxil? a kwadoro maka ọgwụgwọ ọrịa cancer ovarian, multiple myeloma, na sarcoma Kaposi.

Kadcyla? (Trastuzumab Emtansine)

Kadcyla? bụ ADC mejupụtara trastuzumab, mgbochi monoclonal nke na-elekwasị anya HER2, jikọtara ya na emtansine, ihe mgbochi microtubule. Kadcyla? akwadoro maka ọgwụgwọ HER2-positive metastatic cancer ara. Akụkụ trastuzumab nke Kadcyla? na-ejikọta na mkpụrụ ndụ kansa HER2, na-ebuga emtansine ozugbo na saịtị tumor.

Ihe ịma aka na ntụzịaka ga-eme n'ọdịnihu

Imeri ihe mgbochi ndu

Otu n'ime nnukwu nsogbu na nnyefe ọgwụ ezubere iche maka ọrịa kansa na-emeri ihe mgbochi ndu, dị ka mgbochi ụbụrụ ọbara na microenvironment tumor. Usoro iji merie ihe mgbochi ndị a gụnyere iji obere nanoparticles, gbanwee ihe ndị dị n'elu ha, na iji ihe mkpali na-anabata.

Na-emelite nkọwapụta iche

Ịmelite nkọwapụta nke usoro nnyefe ọgwụ ezubere iche dị oke mkpa iji belata mmetụta ndị na-adịghị echere ma kwalite nrụpụta ọgwụgwọ. Enwere ike nweta nke a site n'ịmepụta ligands ndị ọzọ na-ahọrọ, na-eme ka nhazi nke ndị na-ebu ọgwụ na-arụ ọrụ, na iji usoro ọgwụgwọ jikọtara ọnụ.

Ọgwụ ahaziri onwe ya

Usoro ọgwụgwọ ahaziri onwe ya na-ekwe nkwa maka imeziwanye arụmọrụ nke nnyefe ọgwụ ezubere iche maka ọrịa kansa. Site n'ịkwado usoro ọgwụgwọ dabere na njirimara onye ọrịa ọ bụla na etuto ha, ọ ga-ekwe omume ịkwalite nnyefe ọgwụ yana kwalite nsonaazụ ọgwụgwọ. Nke a nwere ike ịgụnye nyocha profaịlụ mkpụrụ ndụ ihe nketa nke etuto ahụ iji chọpụta ebumnuche akọwapụtara maka ịnye ọgwụ.

Tebụlụ FDA-akwadoro sistemu nnyefe ọgwụ ezubere iche maka ọrịa kansa

Nkwuputa: Edemede a bụ maka ebumnuche ozi naanị na ekwesighi iwere ya dị ka ndụmọdụ ahụike. Kpọtụrụ onye ọkachamara ahụike tozuru oke maka nyocha na ọgwụgwọ ọrịa kansa.